Drug class
Antipsychotic Agents clinical trials
A class of medicines: the studies that test any of its 53 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the antipsychotic agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
- Raclopride
- 2
- RP5063
- 2
- Olanzapine, samidorphan drug combination
- 2
- Norclozapine
- 2
And 13 more, each tested in fewer studies.
Studies by the year they started
1,793 studies that test it; most in 2004 (142); 1 more planned to start later
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1993 | 3 |
| 1994 | 4 |
| 1995 | 3 |
| 1996 | 7 |
| 1997 | 9 |
| 1998 | 5 |
| 1999 | 8 |
| 2000 | 25 |
| 2001 | 33 |
| 2002 | 54 |
| 2003 | 95 |
| 2004 | 142 |
| 2005 | 115 |
| 2006 | 121 |
| 2007 | 101 |
| 2008 | 142 |
| 2009 | 84 |
| 2010 | 89 |
| 2011 | 74 |
| 2012 | 92 |
| 2013 | 55 |
| 2014 | 46 |
| 2015 | 40 |
| 2016 | 47 |
| 2017 | 58 |
| 2018 | 42 |
| 2019 | 46 |
| 2020 | 35 |
| 2021 | 45 |
| 2022 | 46 |
| 2023 | 34 |
| 2024 | 40 |
| 2025 | 28 |
| 2026 | 24 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 845 · Other 969
Otsuka Pharmaceutical Development & Commercialization, Inc. (83) · AstraZeneca (69) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (66) · Eli Lilly and Company (39) · GlaxoSmithKline (38) · Sumitomo Pharma America, Inc. (37) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (36) · Organon and Co (29)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 1,814
- Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic SurgeryNot yet recruitingNot applicableQianfoshan HospitalNCT07891312Written as Amisulpride
- Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)RecruitingPhase 2Centre for Addiction and Mental HealthNCT06512220Written as Risperidone 1 MG
- The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.Not yet recruitingPhase 2Washington University School of MedicineNCT07810738Written as Aripiprazole Augmentation
- Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsRecruitingPhase 4Vanda PharmaceuticalsNCT05648591Written as Iloperidone
- Psilocybin Efficacy With or Without Pimavanserin PretreatmentRecruitingPhase 1/2Johns Hopkins UniversityNCT07610135Written as Pimavanserin
- Assessment of Drug Liking In Peri-procedural Clinical SettingsEnrolling by invitationEarly Phase 1Stanford UniversityNCT07015528Written as Droperidol
- Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderRecruitingPhase 3Vanda PharmaceuticalsNCT06830044Written as Milsaperidone
- Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyNot yet recruitingPhase 3Bukwang PharmaceuticalNCT07781293Written as Lurasidone
- Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar DisorderNot yet recruitingPhase 4Martin LanNCT07806227Written as Lurasidone (Latuda)
- Subjective Experience Following PsilocybinRecruitingPhase 2University of CalgaryNCT06768944Written as Risperidone 1 MG
- Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum DisorderRecruitingPhase 2New York State Psychiatric InstituteNCT05999240Written as Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID]
- Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency DepartmentNot yet recruitingEarly Phase 1University of Illinois at ChicagoNCT07726069Written as Haloperidol
- Switching From Twice-Daily to Once-Daily Clozapine Dosing in SchizophreniaRecruitingPhase 4Centre for Addiction and Mental HealthNCT02639702Written as Clozapine
- GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric CancerNot yet recruitingPhase 2University of Illinois at ChicagoNCT07581405Written as Olanzapine
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisRecruitingPhase 4VA Office of Research and DevelopmentNCT04373317Written as Pimavanserin
- Dopamine and Sensorimotor Function in StutteringRecruitingPhase 1University of California, San FranciscoNCT07215884Written as Aripiprazole 10 MG
- Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRecruitingPhase 2Roswell Park Cancer InstituteNCT06995508Written as Olanzapine
- The Impact of Cobenfy Maintenance on Cocaine's EffectsRecruitingPhase 1/2Joshua A. Lile, Ph.D.NCT07624227Written as Cobenfy
- Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsEnrolling by invitationPhase 3Alkermes, Inc.NCT04987229Written as OLZ/SAM
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative DiseasesRecruitingPhase 4Vanderbilt University Medical CenterNCT05357612Written as Pimavanserin
See all 1,814 studies that test one of the antipsychotic agents →
Codes
What other systems call Antipsychotic Agents · ClinicalTrials.gg INT008340
- MeSH (NLM) D014150Antipsychotic AgentsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014150 | Antipsychotic Agents | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.